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Comparison of subcellular responses for the evaluation and prediction
of the chemotherapeutic response to cisplatin in lung adenocarcinoma
using Raman spectroscopy
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Abstract

20

25

30

Confocal Raman Micro spectroscopy (CRM) is employed to examine the chemical and physiological effects of anticancer agents, using
cisplatin and A549 adenocarcinoma cells as a model compound and test system respectively. Spectral responses of the membrane and
cytoplasm of the cell are analysed independently and the results are compared to previously reported spectroscopic studies of the nucleus.
Moreover, Raman spectra from the proteins extracted from the control and exposed samples are acquired and analysed to confirm the
origin of the molecular changes of the cell membrane and cytoplasm of the A549 cells. Multivariate data analysis techniques including
Principal Component Analysis (PCA) and Partial Least Square Regression (PLSR) along with PLS-Jack knifing are used to analyse the
data measured from the cell membrane and cytoplasm of the A549 cells and results are correlated with parallel measurements from the
cytotoxicity assay MTT. A PLSR model is used to differentiate between the chemical effect of the chemotherapeutic agent and the
physiological response of the A549 cells and to identify regions of the spectrum that are associated with these processes respectively. The
PLSR model is also employed to predict, on the basis of the Raman spectra, the effective dose as well as the level of physiological
response, using spectra data from the cytoplasmic and cell membrane regions. The effectiveness of the models based on spectral datasets
from the cell membrane and cytoplasm is compared to similar models constructed using spectral data from the nuclear region as well as
one combining spectral data from all regions. In all cases, higher prediction accuracy is found for regression against the cisplatin dose,
and for both regression against dose and physiological response, nuclear data yields higher precision.

This journal is © The Royal Society of Chemistry [year]
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Introduction

crosslinks which lead to cell cycle arrest and apoptosis, the
primary cytotoxicological response 21.
In the current study, the capabilities of CRM for the
elucidation of the mechanism and efficacy of
chemotherapeutic agents are further evaluated by exploring
the spectral changes in the cell membrane and cytoplasm,
65 using cisplatin and A549 adenocarcinoma cells as a model
compound and test system respectively. Spectra of the cell
membrane and cytoplasm of A549 cells were taken after a
96 hour exposure period to the agent, and multivariate
models of the variation in spectral content with levels of
70 exposure and degrees of cytotoxicological response, as
determined by the MTT assay were constructed. A feature
selection technique was then used to identify regions of the
spectrum that were associated with the biochemical effect
of exposure to the agent, and with the subsequent
75 cytotoxicological
response of the cells. Finally,
multivariate Partial Least Squares Regression is used to
demonstrate the capabilities of Raman spectral analysis to
predict both the exposure dose and viability of the cell
culture and results are compared to those previously
80 reported for spectroscopic analysis of the nuclear regions
only13.
60

The study of the interaction of anticancer agents with
cancer cell model systems is considered to be very
5 important at the preclinical stage of the drug development
process in order to establish the mechanism of action of the
drug as well as the response of the cell to the
chemotherapeutic agent. There is great need for the
development and establishment of a non-invasive
10 analytical technique which not only can be used for the
analysis of the binding mechanism of the anticancer agents
to their targets but which can also analyse the biological
processes of the cell which occur in response to the action
of the drug and ultimately predict the drug efficacy.
15 Confocal Raman Micro spectroscopy (CRM) has emerged
as a viable analytical tool for the analysis of biological
tissue 1 and the effect of external agents on the cell 1-5. The
technique is being explored extensively for the analysis of
biological systems because it is non-invasive, cost
20 effective, rapid, requires no sample labelling prior to
analysis and gives high content information 6. It is capable
of investigating sub-cellular biochemical structures 7, 8 and
has already been explored for the analysis of the
interaction of a range of chemotherapeutic agents with
9
25 biological macromolecules
and with cancer cells 6, 10-12.
In order to validate the technique of CRM for quantitative
measurement of the biochemical and physiological effects
of novel chemical treatments, it is necessary to
demonstrate and evaluate the technique for anticancer
30 agents whose mechanism and efficacy of action is well
known. The use of CRM for the analysis and prediction of
the chemotherapeutic response of A549 cells to the action
of the cisplatin (cis-Diamminedichloroplatinum (II)), based
on analysis of the nuclear signals, has recently been
13
35 demonstrated
. The use of both cisplatin dose, as well
cellular response as defined by the cytotoxicity assay,
MTT, as targets for PLS regression enabled a
differentiation between the spectral changes associated
with the direct chemical interaction with the nucleus and
40 the resultant metabolic response.
It is also of great importance to understand and
characterize the biochemical changes in the membrane and
cytoplasm of cells during the course of the action of
chemotherapeutic agents. These can occur due to the
45 primary interactions during uptake of the agent, but also as
a result of the subsequent cellular response. Cisplatin is
widely used to treat a variety of cancers including lung,
ovarian, colon, cervical, bladder, head and neck and
testicular cancers, either as an individual agent or in
50 combination
with other drugs14-17. Its mechanism of
chemical interaction is well characterised. While entering
the cell, cisplatin interacts with lipids of the cell membrane
which may affect the function of the cell membrane 18,
while inside the cytoplasm, it may bind to RNA and thiol
19
55 groups of peptides and proteins
. In the cytosol, binding
of cisplatin with some proteins may lead to the
development of cytoxicity and resistance 20. In the nucleus,
it binds with DNA forming inter-strand and intra-strand
2 | Journal Name, [year], [vol], 00–00

Materials and methods
85

Cell culture

A549 human lung adenocarcinoma cells were obtained
from ATCC (CCL-185). The cells were cultured in DMEM
F-12 (Sigma Aldrich, Ireland) medium supplemented with
90 10% FBS,
1µg/ml hydrocortisone (Sigma), 2mM Lglutamine (Gibco) and 1% penicillin- streptomycin
(Gibco). Cells were incubated at 37°C in 5% CO2 and
routinely subcultured with a 1:1 ratio of 0.25% trypsin and
0.1% EDTA when they reached 70-80% confluency.
95

Cell exposure and cytotoxicity assay

Cisplatin, obtained from Sigma Aldrich, Ireland, was
dissolved in 1% NaCl (Sigma Aldrich, Ireland) solution
100 (pH 7) to prepare the stock solution. Working solutions of
the drug were prepared in cell culture media. A 96-hour
period of exposure to cisplatin was chosen along with a
wide range of exposure concentrations ranging from 0.0550 µM, as this covers the range of the cytotoxic response
105 and provided a dataset upon which to base a regression
model to demonstrate the predictive ability of the Raman
spectral measurements. Cytotoxicity was measured
according to the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5diphenyl tetrazolium bromide] assay, obtained from Sigma
110 Aldrich, Ireland. MTT is a molecular assay whose colour is
changed by mitochondrial reductases in living cells, and it
is therefore commonly used as an indicator of cell viability
and proliferative capacity and thus the cytotoxicity of
chemical agents.

This journal is © The Royal Society of Chemistry [year]

The MTT assay was performed in triplicate according to a
method reported previously 22 with a slight modification 13.
Cells were cultured in 96-well plates (Nunc, Denmark) at a
3
5 density of 2 × 10 cells per well in DMEM-F12 medium
with all the supplements as listed above. After 24 hrs of
initial cell attachment, the plates were washed with 100
µl/well phosphate buffered saline (PBS) and were treated
with varying concentrations of cisplatin in the range from
10 0.05 µM- 50µM (including a separate unexposed control
sample). Following a 96-hour exposure period, the cells
were rinsed with PBS and 100 µl of fresh medium (without
supplements) were added to each well. A volume of 10 µl
of MTT (5mg/ml) prepared in PBS was then added to each
15 well and the plates were incubated for 3 hrs at 37 °C in a
5% CO2 humidified incubator. After this incubation period,
the medium was discarded, the cells were washed with 100
µl of PBS and 100 µl of DMSO was added to each well to
extract the dye. The plates were then shaken 240 times per
20 minute for 10 min and the absorbance was measured at 570
nm using a micro plate reader (Tecan Genios, Grodig,
Austria). Six replicate wells were used for each exposure.
Protein extraction
25

The cellular protein was extracted from both a control
sample of A549 cells together with a sample of A549 cells
exposed to 3 µM cisplatin for 96 hours. The 3 µM
exposure level was chosen as it provided the means to
30 examine the ability of CRM to identify relatively small
levels of changes in protein, structural and conformational,
as a result of cisplatin binding. As determined using the
cytotoxicity assay, at this concentration, the viability has
reduced to approximately 30% and thus it represents the
35 inverse exponential point of the response. Briefly, cells
were trypsinised and centrifuged to form a pellet of cells,
and 1 ml TRIzol reagent (Invitrogen) per 5 - 10 × 106 cells
was added. The samples were then homogenized and
incubated at room temperature for 5 min to induce cell
40 lysis. For each ml of TRIzol reagent, 200 µl of chloroform
was added and samples were centrifuged at 12,000 × g for
5 min at 4 °C. Following centrifugation, the mixture
separated out into a lower red organic phase, a thin
interphase and a colourless upper aqueous phase. Then 300
45 µl of 100% ethanol per ml of TRIzol reagent was added to
the interphase and organic phase followed by mixing and
spinning which yielded a pellet and supernatant. The
supernatant was used to extract the proteins. To precipitate
proteins, 1.5ml of isopropanol/ml of Trizol reagent used
50 was added for initial homogenization. The samples were
stored at room temperature for 10 minutes and sedimented
by centrifugation at 12000xg for 10 min. and 4 °C. The
supernatant was removed and the protein pellet was
washed three times with 0.2M guanidine thiocyanate to
55 remove phenol and dye. After the final wash, the protein
pellet was vortexed in 2 ml 100% ethanol and was stored
in ethanol for 20 minutes at room temperature. After that,
the pellet was air dried and dissolved in 1% SDS (Sodium
This journal is © The Royal Society of Chemistry [year]

Dodecyl Sulphate) and then incubated at 50 °C, to extract
the proteins from the pellet. The insoluble material was
sedimented by centrifugation at 10,000 g for 10 min. at 4
°C and the supernatant containing total cellular proteins
was transferred into a clean tube. To get the proteins in
pellet form from this supernatant, acetone precipitation of
65 the proteins was performed. To do this, equal volumes of
the ice-cold acetone was added to the protein supernatant
and incubated on ice for 15 minutes followed by the
centrifugation for 10 min. at 12000 x g in a pre-cooled
microcentrifuge at 4 ë. The supernatant was discarded and
70 pellet was air dried. In order to verify the purity of the
proteins, the absorbance of the sample was recorded on a
UV-Vis spectrophotometer at 260nm and 280nm. A ratio
of 0.6 (A260/A280) is characteristic of pure protein. The
pellet was dissolved in dH2O, as water has a significantly
75 weaker Raman signal than common organic solvents, and
was used immediately for analysis by Raman
spectroscopy.
60

Sample preparation for Confocal Raman Spectroscopy
80

For CRM, cell samples were cultured on quartz substrates
according to a protocol outlined elsewhere 1. Briefly,
quartz coverslips were coated with a 2% w/v gelatin-water
solution and maintained at 4 °C for 6 hrs to allow
85 polymerization
of the gelatin to the substrate.
Subsequently, 2.5 × 103 A549 cells were attached to the
substrates for a 48 hour period, and were exposed to the
cisplatin concentrations in the range 0.05 µM- 50µM for a
96-hour period (together with a non-exposed control
90 sample). After the exposure period, the cells were fixed in
4% formalin for 10 minutes and were stored in 0.9 %
physiological saline solution at 4 °C until the Raman
analysis was performed 5. Fixing the cells allows
prolonged periods of storage and measurement. In a
95 previous study, it has been demonstrated that although all
commonly employed fixatives result in some degree of
nucleic acid degradation, protein denaturation, and lipid
leaching, fixing in formalin, in comparison to other
fixatives, best preserves the integrity of the cells compared
5
100 to live cells. All samples were prepared in triplicate.
Spectral Acquisition

CRM was conducted with a Horiba Jobin-Yvon, LabRam
HR800 instrument using a 785 nm laser as source. The
laser power was approximately 70 mW at the sample.
Spectra were taken in the range from 600 cm-1 to 1800 cm1
with a confocal hole diameter of 100µm. A ×100 water
immersion objective was used to focus the laser on the
110 sample, immersed in 0.9% saline. The spatial resolution of
the instrument has previously been checked by performing
a linescan of 1µm Iron oxide particles with a 0.2 µm step
size, which produced a profile of 1.5µm FWHM, implying
a spotsize of 1.12µm7.Multiple spectra were recorded from
115 the cell membrane and cytoplasm portion and nucleus for a
previously reported study13 of a total of 60 cells at each
105
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cisplatin exposure level, by performing a line scan across
each cell as illustrated in Figure 1(a). Each scan was set
up by initially focussing on the nucleus of the cell.
Subsequently, the spectra were filtered with a Savitsky5 Golay filter (order 5, 13 point window), and the quartz
signal background was subtracted using algorithms
developed in-house. Prior to analysis, the spectra were also
vector normalized. For the acquisition of the spectra from
the extracted protein, the protein dissolved in water was
10 drop cast onto quartz substrates immediately prior to
measurement.
Data analysis

All spectral analysis was performed in the Matlab 7.2 (The
Mathworks Inc.) environment employing the PLS Toolbox
5.0.3 (Eigenvector Research, Wenatchee, WA) and
algorithms developed in-house. Outlying spectra were
removed using Grubb’s filtering 23. All spectra, including
calibration and substrate backgrounds, were vector
20 normalized. The substrate spectra were subtracted from
each spectrum and a fifth order polynomial was fitted to
and subtracted from the spectra to remove any residual
spectral baseline. Multivariate regression models were
constructed using Partial Least Squares Regression (PLSR)
24
25
and PLS Jack-knifing was employed as a multivariate
feature selection technique 25-27. The PLSR algorithm seeks
to develop a model that relates the spectral data (X-matrix)
to a series of targets (Y-matrix, e.g. concentration of
reaction product or analyte) according to the equation
30 Y=XB+E, where B is a matrix of regression coefficients
and E is the regression residual. The Y-matrix here
consisted of values of the concentration of cisplatin to
which the cell was exposed, or the measured level of cell
viability from the MTT assay. The PLS Jack-knifing
35 method developed by Martens and colleagues was then
used to determine the spectral features that were
statistically significant at a particular level of confidence
using t-testing of the regression coefficients, B. 27. The
Raman band assignments used in interpretation of the
28-32
40 spectral features were taken from the literature
.

15

Results and Discussion
45

Comparison of the mean control spectra of the cell
membrane, cytoplasm and nucleus

The mean control spectra of the cell membrane, cytoplasm
and nucleus of A549 cells are shown in Figure 1(b). The
mean control spectra of all the three cellular components
50 appear similar to the naked eye. In a similar analysis of
live cells using K-means clustering, the nuclei, cytoplasm
and membrane were clearly differentiated and spatially
located, but the average K-cluster spectra showed similarly
few identifiable spectral differences7. This is perhaps not
55 surprising as, with a 1µm spot size, the nucleus can be
specifically targeted, but the overlying cellular membrane
and cytoplasm will also contribute to the spectrum
acquired. Similarly, the spectrum of the cytoplasm will

4 | Journal Name, [year], [vol], 00–00

contain contributions from the overlying cellular
membrane and potentially also from subcellular organelles
such as mitochondria, lysosomes, etc., and inevitably the
spectra of the cell membrance will contain contributions
from the neighbouring cytoplasm.
Careful analysis of the spectra reveals however some
65 differences which distinguish the spectra of the cell
membrane and cytoplasm from the nucleus as
demonstrated by the scatter plot of the Principal
Component Analysis (PCA) shown in Figure 2(a). There
is very good separation indicating that the spectra for the
70 three
cellular components are different and these
experimental settings can be used for acquiring reliable
spectra from the samples. The cellular regions are
effectively separated according to PC1 which accounts for
95.58% of the variance and the spectral loadings are
75 illustrated in Figure 2(b). The Raman bands which
differentiate the mean control spectra of the three cellular
components are indicated by arrows (and by solid lines in
Figure 1(b)) and these are also bands in which changes
due to the action of the cisplatin are expected. The band at
-1
80 726 cm , which can be assigned to tryptophan and/or CH3
stretching of the lipids, is present in the cytoplasm and cell
membrane spectra but is not prominent in the nuclear
spectra. The Raman band at 1423 cm-1 is assigned to CH3
deformation of aromatic lipids and is present in the spectra
85 of the cell membrane and cytoplasm but is similarly not
prominent in the spectra of the nucleus. Another band at
1510 cm-1, assigned to C=C stretching of proteins
(Tryptophan, Tyrosine amino acids), is present in the mean
spectra of the membrane and cytoplasm but absent in the
90 nuclear mean spectra. The two Raman bands which are
present in all three mean spectra, indicated by dotted lines,
correspond to C-H deformation of lipids/proteins (1449
cm-1) and the amide-I band for proteins (1660 cm-1). Due
to the action of the cisplatin, changes in these bands are
95 also expected.
For the nuclear mean spectra, the important Raman peaks
which are different from the spectra of the cytoplasm and
cell membrane are labelled. The Raman band at 718 cm-1
can be assigned to adenine while the bands at 807 cm-1 and
-1
100 827 cm
are assigned solely to O-P-O stretching of the
DNA-A and B-form respectively and that at 1065 cm-1
assigned to the O-P-O stretching of the DNA backbone in
general. These three Raman markers of the DNA backbone
are present in the spectra of the nucleus with much higher
105 intensity as compared to the spectra of the cytoplasm and
membrane. The Raman bands at 669 cm-1 (Thymine) and
1336 cm-1 (Guanine) are present, both in the mean spectra
of the nucleus and cytoplasm which is expected, as their
presence in the cytoplasm may be due to cytoplasmic
110 DNA, and are unexpectedly seen in the membrane spectra
which may be the contribution from the surrounding
cytoplasm 29.
Comparing the mean control spectra of the nucleus of
A549 cells with that of the cell membrane and cytoplasm,
115 ideally, there should be no peaks in the nuclear spectra for
the lipids (CH deformation, 1449 cm-1) but their presence
60

This journal is © The Royal Society of Chemistry [year]

may be due to the contribution from the surrounding
cytoplasm 33 and 29 or on the other hand this band can be
assigned, both to lipids and proteins 34.
5

Cytotoxicity of cisplatin

The dose response curve representing the cytotoxic
response of cisplatin to A549 cells after 96 hrs is presented
in Figure 3 (reproduced from results published
13
10 elsewhere) , where the level of viability in each sample
was normalised to that in the control sample. Due to the
action of the drug, the mitochondrial activity decreases
monotonically which in turn leads to a decrease in cell
viability. The Inhibitory Concentration (IC50) value was
15 derived from the data by a fit of f(x) = min + (maxmin)/(1+(x/IC50)^n) and found to be 1.2 ± 0.2µM, which is
consistent with the literature. For A549 cells exposed to
test drug concentration (TDC) for 72 hrs, IC50 values of
3.59µM and 2.2 µM are reported elsewhere with MTT and
35
20 ATP assays respectively
. Also, Cordes et al. have
determined an IC50 value of 2.0 µM for cisplatin (0.1-50
µM) exposed A549 cells using the colony formation assay
36
.
Figure 1 a: Image of an A549 cell (control) showing the range of a
typical line map, as well as the points at which Raman spectra were
recorded.

25

85

95

105

130

140

Figure 1 b: Mean control spectra of the (nucleus, cytoplasm and cell membrane) of A549 cells, the spectra are normalized and off set for
clarity and shading shows the error bars.

This journal is © The Royal Society of Chemistry [year]
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Figure 2 a: Scatter plot of the Principal Component Analysis of the spectra of the nucleus, cytoplasm and cell membrane of control A549 cells
35

Figure 2 b: Loadings of PC1 from the Principal Component Analysis of the Raman spectra taken from the nucleus, cytoplasm and cell membrane of the control A549 cells.

6 | Journal Name, [year], [vol], 00–00
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Figure 3: A549 cell viability (measured by MTT absorbance) at 96 hours after exposure to Cisplatin. Error bars denote the standard error on the
mean at each concentration.

Effect of cisplatin exposure on the spectra of cell membrane

Figure 4 shows the mean control (A) and difference
spectrum of the cell membrane (B) of A549 cells exposed
to 3 µM cisplatin versus its control. It should be noted that
no significant contributions due to the cisplatin itself are
expected, as its Raman spectrum is dominated by bands in
-1
35 the region between 100-550 cm
(Nawaz et al., 2010),
which does not fall within the 600-1800 cm-1 spectral
window of the current measurements. The most prominent
changes are observed in the bands related to proteins at
671 cm-1 and 728 cm-1 (ring breathing of the tryptophan),
-1
40 1030cm
(C-H bending), 1094 cm-1and 1126 cm-1 (C-N
stretching) and 1655 cm-1 (amide-I). In addition to this,
shifts in some of the Raman bands are also observed,
including 1094 to 1097 cm-1 and 1126 to 1129 cm-1 (C-N
stretching) and 1655-1659 cm-1 (amide-I) as labelled in the
45 mean difference spectra.
The Raman bands at 1371 cm-1 (CH3 stretching) and 1448
cm-1 (CH deformation), related to cell membrane lipids,
also undergo shifts from 1371 to 1376 cm-1 and 1448 to
1450 cm-1. These spectral changes and shifts in the Raman
50 signatures
of the membrane proteins and lipids are
consistent with the well known direct interaction of
cisplatin 37 and may also provide indications of the indirect
action of the agent on cellular function 18.
30

55

Mean control and difference spectra of the cytoplasm

This journal is © The Royal Society of Chemistry [year]

The mean control and difference spectra of the cytoplasm
of A549 cells exposed to 3 µM cisplatin are shown in
Figure 5 A and B respectively. The bands in which the
major changes are observed are related to proteins, and
include 671 cm-1, 728 cm-1, 1210 cm-1 (Tryptophan ring
-1
90 breathing), 939 cm , (C-C skeletal stretching, ά-helix),
-1
1129 cm (C-N stretching), 1179 cm-1 (C-H bending,
Tyrosine), 1260 cm-1 (amide-III, β-sheets) and 1658 cm-1
(amide-I) along with shifts in some bands like 671 to 674
cm-1, 728 to 731 cm-1, (Tryptophan ring breathing), 1260 to
-1
95 1265 cm
(amide-III, β-sheets) and 1658 to 1661 cm-1
(amide-I) as labelled in the mean difference spectra. These
changes can be important Raman signatures of the binding
of the cisplatin with the proteins in the cytoplasm of the
cell 19 which may lead to the development of cytoxicity
20
100 and resistance
and cause changes in their secondary and
tertiary structures.
85

Spectra of extracted protein

In order to further confirm the Raman markers for the
direct chemical action of cisplatin and the cytotoxic
response of the A549 cells to the cisplatin exposure from
the cell membrane and cytoplasm, the spectra recorded of
the protein extracted from the control and exposed (3 µM
110 for comparison to the spectroscopic analyses of the cells)
A549 cells were analyzed. The mean control and the
difference spectra of the extracted protein are shown in

105
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Figure 4: Mean spectrum of the cell membrane of control sample (A) and the difference spectrum (B) between the mean of the control and the sample exposed to 3µM
cisplatin. The shaded area around each trace defines the standard error on the mean.

Figure 5: Mean spectrum of the cytoplasm of control sample (top) and the difference spectrum (bottom) between the mean of the control and the sample exposed to 3µM
cisplatin. The shaded area around each trace defines the standard error on the mean.
65
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Figure 6. The major changes observed in the Raman bands
include an increase in the intensities of the C-C skeletal
stretching (904 cm-1, 935 cm-1), phenyl alanine (1001 cm1
), C-N stretching (1061 cm-1, 1131 cm-1), Tyrosine ring
-1
-1
-1
5 breathing (639 cm , 961 cm , 1199 cm ), Tryptophan ring
-1
breathing (1011 cm ), CH deformation (1323 cm-1 and
1404 cm-1 ) and C=C bending (1606 cm-1).
It should be noted that the extract does not differentiate
between membrane and cytoplasmic proteins and that the
10 in situ cellular environment is very different from that of
the ex situ dried state, and thus that the spectral changes of
figure 6 cannot be quantitatively compared to those
observed in the cells. Nevertheless, the spectral changes in
the protein extracted from cisplatin exposed compared to
15 control cell cultures confirms a significant modification of
the protein structure as a result of the exposure, by direct
or indirect means. Normally, in a cell, proteins are folded
in a well-ordered structure and the side chains of the
proteins are constrained 34 and thus the intensities of these
20 Raman bands are suppressed in the spectrum of the control
as compared to the exposed. The increase in the intensities
of these bands may be due to the direct binding of the
cisplatin to the associated proteins which causes changes in
their secondary structure and causes their unfolding,
25 exposing
the phenylalanine/tyrosine/tryptophan side
chains. These changes can be taken as the Raman
signatures of the known action of the cisplatin binding to
proteins in the cell membrane and cytoplasm 19 of A549
cells. Moreover, changes in the amide-I band (1660 cm-1)
-1
30 along with a shift (1660 to 1665 cm ) and amide-III, β-1
sheet (1252 cm ) along with a shift (1252 to 1257 cm-1),
are also observed. These two Raman bands are frequently
used to allocate secondary structure to the proteins 38 and
the shifts observed in these bands can be the Raman
35 markers of the conformational changes in the associated
proteins as a result of the action of the cisplatin.
The changes observed in the Raman spectra of the
extracted proteins can also be identified in the mean
control and difference spectra of the cell membrane or
40 cytoplasm or both albeit with slight deviations of their
positions. Notably prominent in both are the bands related
to C-C skeletal stretching (904 cm-1, 935 cm-1), C-N
stretching (1131cm-1), Tyrosine ring breathing (1199 cm-1),
CH deformation of the proteins (1449 cm-1) , amide-I band
-1
-1
45 (1660 cm ) and amide-III, β-sheet (1252 cm ). These
results confirm those obtained from the data of cell
membrane and cytoplasm.

50

Feature Selection by PLS Jack-knifing for the data of the Cell
membrane

For a fixed exposure concentration, the analysis of the
mean difference spectra for cytoplasm and cellular
membrane highlight the effects of the cellular interaction
55 with the cellular structures which can be the result of the
direct chemical interaction of the agent or the resulting
physiological (cytotoxic response). The former should be
correlated with the applied dose, whereas the latter should

This journal is © The Royal Society of Chemistry [year]

be correlated with the physiological response (Figure 3).
In an attempt to differentiate the responses, the spectral
data, for each cellular region, over the whole exposure
range, were subjected to a multivariate Partial Least
Squares Regression (PLSR), using the chemical
concentration and cytotoxicological response, respectively.
65 The
PLS Jack-knifing procedure was furthermore
employed to identify the spectral features of maximum
variance as a function of the respective parameters.
The regression co-efficients obtained by PLS-Jack knifing
for the cell membrane data, regressed against cisplatin
70 concentration (Figure 7 A), give useful information
regarding the signatures of the cisplatin attack on the cell
membrane while entering the cell (chemical effect). As a
result of interaction with the cisplatin, significant changes
in the bands related to lipids at for example 1420-1426 cm1
-1
-1
75 , 1436-1440 cm , (CH3 deformation) and 1447-1466 cm
-1
, 1474-1483 cm (CH deformation) are observed, which
may be indicative of the interaction of the cisplatin with
the membrane lipids. Also, a positive shift of the band at
1449 cm-1, (C-H deformation) to 1466 cm-1 is observed in
80 the mean difference spectra, (Figure 3 B), On the basis of
the information derived, it seems that cisplatin interacts
with the membrane lipids and causes some changes in their
structure. It has been reported by 37 that cisplatin interacts
with the membrane lipids which can cause neurotoxicity
85 and that this interaction with the lipid bilayer can cause an
increase in the isotropic/hexagonal lipid phases at the cost
of the lamellar phase.
Further changes at 713-717 cm-1, 833-842 cm-1, 1556-1563
cm-1 associated with tryptophan ring breathing along with
-1
-1
90 the changes in the bands at 622-627 cm , 852-860 cm ,
-1
1135-1147 cm assigned to C-C stretching vibrations and
1122-1129 cm-1, 1161-1163 cm-1 assigned to C-N
stretching vibrations, 1485-1495 cm-1 (C-H deformation of
proteins) are related to the proteins. Additionally, changes
95 in the bands at (1242-1244, 1246-1255) assigned to amideIII β-sheets and at (1270-1316) of amide-III ά-helix and
(1649-1652, 1659-1685) assigned to amide-I ά-helix are
also observed. These changes can be attributed to the
structural changes occurring in the proteins of the cell
100 membrane due to the attack of the drug, as also discussed
in the information observed in the mean difference spectra
of the cell membrane.
The regression co-efficients obtained by PLS-Jack knifing
for the cell membrane data, regressed against cell viability
105 (physiological effect), are shown in Figure 7 B. The bands
of ring breathing of tryptophan (711-736 cm-1, 748-753
cm-1, 758-774 cm-1), out plane ring breathing of tyrosine
(826-830 cm-1), and C-C skeletal vibrations (883-898 cm1,
903-923, 928-931, 934-935) along with C-N stretching
-1
-1
110 (1111-1116 cm , 1120-1129 cm ) and CH2 rocking (740-1
744 cm ) are related to proteins which can be attributed to
the changes in the secondary and tertiary structures of the
proteins due to the changes in the physiology of the cell
and others in the stretching vibrations of the C-C head
-1
115 group of the lipids (939-980 cm ), CH deformation of the
60
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Figure 6: Raman spectra of protein extracted from A549 cells; Mean of the control and exposed to 3 µM cisplatin for 96 hrs (A), the zoomed in region, 1199-1800, (A-1),
difference spectra (B) and the zoomed in region, 1199-1800, (B-1). The shaded area defines the standard error on the mean.
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Figure 7: PLS-Jack knifing analysis, A (regressed against cisplatin concentrations) and B (regressed against cell viability) of the cell membrane spectra of A549 cells
exposed to 0.05µM-50µM cisplatin for 96 hrs.

lipids (1424-1439 cm-1, 1445-1455 cm-1), provide the
Raman signatures of the structural changes in the
membrane lipids as a result of the changes in the
physiology (cell viability) of the cell.
Comparing the regression co-efficients obtained via
45 spectral regression against cisplatin concentrations (which
highlight the primary chemical effect of the action of the
agent) with those obtained via regression against cell
viability (which highlight biochemical markers of the
change in the viability of the cell), very different spectral
50 features are selected as being statistically significant and
thus allow the differentiation of the chemotherapeutic
response.
The spectral features which are changed only due to the
chemical effect and not due to the physiological effect are
-1
55 bands related to lipids 1270-1316 cm
(CH2 twist), 1420-1
-1
1426 cm , 1436-1440 cm , 1447-1466 cm-1 (C-H
deformation) and bands related to proteins including 14851495 cm-1 (C-H deformation of proteins), (713-717 cm-1,
833-842 cm-1, 1556-1563 cm-1) of tryptophan ring
40

This journal is © The Royal Society of Chemistry [year]

breathing among others. This may indicate that the
chemical interaction of the cisplatin with the membrane
100 proteins and lipids results in disintegration of the lipids and
changes in the conformation of the membrane proteins.
On the other hand, the spectral features which are changed
only due to the physiological effect and not due to the
chemical effect are related mainly to the proteins of the
-1
105 cell membrane 877-881 cm (Glutamine residues), 883-1
-1
898 cm , 903-923 cm , 928-931 cm-1, (C-C skeletal
stretching), 958-987 cm-1 (C-C skeletal β-sheets) which
may be due to the membrane protein signalling as a result
of the attack and action of the cisplatin on the cell
110 membrane.
Feature Selection by PLS Jack-knifing for the data from
Cytoplasm
115

For the cytoplasm data, the regression co-efficients
obtained by PLS-Jack knifing, are shown, for regression
against cisplatin concentrations (Figure 8 A) and against
cell viability (Figure 8 B).
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As a result of the chemical effect (Figure 8 A), features
primarily related to proteins are identified. In addition to
the observations of the same Raman bands for proteins as
5 observed in the mean difference spectra (Figure 4 B), Jack
knifing results for cytoplasm data show that there is a
positive shift of the amide I band from 1664 cm-1 to 1676
cm-1 with increasing cisplatin concentration, which may be
indicative of the changes in the secondary and tertiary
10 structure of the protein.
The regression against the cell viability (Figure 8 B)
shows features related to the change in the cell physiology
due to the action of the cisplatin and include tryptophan
ring breathing (714-715 cm-1, 724-727 cm-1, 764 cm-1), CH
15 bending (1390-1393) and also, ribose ring breathing of the
RNA (1057 cm-1) and many others which are highlighted.
The changes which are seen only due to the chemical
effect and not due to the physiological effect include bands
assigned to out of plane ring breathing of tyrosine (824 cm1
-1
20 ), related to C-C stretching vibrations (862 cm ), C-N
-1
stretching (1073-1074 cm ), C-C stretching related to
skeletal changes of proteins.
On the other hand, the changes which are seen only due to
the physiological effect and not due to the chemical effect
-1
25 are related to tryptophan ring breathing (714-715 cm ,
-1
-1
-1
724-727 cm , 764 cm ), CH bending (1390-1393 cm )
and also, ribose ring breathing of the RNA (1057 cm-1).

30

PLS-model for the prediction of levels of the exposures and
cellular viability

CRM can clearly fingerprint the effects of the interaction
of the chemotherapeutic agent within the cellular regions
and identify that fingerprint within the cellular spectra of
35 exposed cells. PLSR models of A549 cellular membrane
and cytoplasmic spectra versus concentration and viability
measurements from the MTT assay were constructed to
determine the ability of the Raman spectral data to predict
the level of exposure to cisplatin and the resultant
40 physiological effect.
For the construction of the PLSR model, all spectra of each
cellular region were compiled into a matrix, and were
randomly sorted. A total of 60% of the spectra were used
to train the PLSR regression model and 40% of the total
45 was retained as an independent test set to assess the
performance of the model in predicting the level of
exposure, and the cellular viability, with unseen data.
Leave-one out cross validation with the calibration set was
used to determine the optimal model complexity for use in
26
50 testing
. This process was performed on fifty separate
occasions, with randomization of the data matrix and
splitting of the data on each occasion to prevent data bias
24
. The reliability/uncertainty of the model can be
determined from the results from the values of the root
55 mean square error of calibration (RMSEC) and the root
mean square error of prediction (RMSEP). Control of
overfitting was achieved using a procedure previously
described by Martens and Naes39. The procedure involves
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selection of the optimal number of latent variables to retain
within the PLS model via ten-fold cross-validation with the
calibration data set. The optimal number of LV's was then
selected on the basis of the number which provided the
lowest root mean squared error at cross validation.
An example of the results of the PLSR model prediction of
65 the cellular viability for the cell membrane data is shown
in Figure 9, where the values of the root mean square error
of calibration (RMSEC) and the root mean square error of
prediction (RMSEP) denote the prediction uncertainty. The
mean values of the RMSEC and RMSEP for the PLSR for
70 prediction of the level of exposure to cisplatin (from the
spectra of cell membrane) were found to be 3.01 µM and
4.74 µM respectively. The associated values of RMSEC
and RMSEP for PLSR against normalized cellular viability
were 0.06 and 0.12 respectively. The RMSEP for
75 prediction of cisplatin concentration is therefore 9.48%
over the full scale range (0 to 50 µM), and 12% over the
full scale range of viability (from 0 to 1).
The mean values of the RMSEC and RMSEP for the PLSR
for prediction of the level of exposure to cisplatin (from
80 the spectra of cytoplasm) were found to be 1.47 µM and
3.74 µM respectively. The associated values of RMSEC
and RMSEP for PLSR against normalized cellular viability
were 0.07 and 0.14 respectively. The RMSEP for
prediction of cisplatin concentration is therefore 7.48%
85 over the full scale range (0 to 50 µM), and 14% over the
full scale range of viability (from 0 to 1).
In the previous study of the nuclear spectra of the same
system, the mean values of the RMSEC and RMSEP for
the PLSR for prediction of the level of exposure to
90 cisplatin were found to be 1.67 µM and 3.41 µM
respectively. The associated values of RMSEC and
RMSEP for PLSR against normalized cellular viability
were 0.05 and 0.11 respectively. The RMSEP for
prediction of cisplatin concentration is therefore 6.8% over
95 the full scale range (0 to 50 µM), and 11% over the full
scale range of viability (from 0 to 1).
Furthermore, the spectral data from cell membrane,
cytoplasm and nucleus was combined and a PLSR model
was constructed to predict the level of exposure and
100 cellular viability on the basis of the combined spectral
changes. The values of the RMSEC and RMSEP for PLSR
for prediction of level of exposure were found to be 6.44
and 8.15 µM and against the normalised cellular viability
0.148 and 0.186 respectively. The RMSEP for prediction
105 of cisplatin concentration is therefore 16.3 % over the full
scale range (0 to 50 µM), and 18.6 % over the full scale
range of viability (from 0 to 1).
Table 1 summarises the prediction accuracies of the PLSR
models based on the individual cellular components as
110 well as the combined data, for regression against both the
cisplatin dose and the cell viability. Figures in brackets
denote standard deviations. In all cases, higher prediction
60
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Figure 8: PLS-Jack knifing analysis, A (regressed against cisplatin concentrations) and B (regressed against cell viability) of the cytoplasm spectra of A549 cells exposed to
0.05µM-50µM cisplatin for 96 hrs.

accuracy is found for regression against the cisplatin dose,
and for both regression against dose and physiological
response, nuclear data yields higher precision.
5 As cisplatin primarily interacts with DNA in the nucleus,
the largest effects of the agent are manifest there, either
due to the direct chemical interaction of the drug or due to
the physiological response of the cell to it. This may be the
reason why the PLSR model gives the highest prediction
10 accuracies for both the level of exposure and cell viability,
for the nuclear data.
It should further be noted that PLSR is a linear model, and
is thus limited for a nonlinear response. In operational
models of pharmacological agonism, the relationship
15 between the agonist concentration and that of receptors
occupied by the agonist is in itself a hyperbolic function 40
and thus it may be expected that the direct chemical effect
as a result of the interaction of cisplatin with nuclear DNA

This journal is © The Royal Society of Chemistry [year]

or other subcellular molecular components, as monitored
by Raman spectroscopy is not a linear function. The
dependence of the physiological effects on the agonist
concentration is a further complex function, as a result of
the ensuing biochemical cascades, but is generally
25 described by the operational equation employed to fit the
cytotoxicity data of Figure 3. It may be expected therefore
that a regression of the spectral data against the
physiological effect as expressed by the cell viability
should yield a more precise result. However, it has been
30 demonstrated for the case of low dose radiation responses
in cellular systems, that the spectral responses are not
linearly dependent on the physiological responses as
measured by cytoxicological assays 41 Furthermore, it may
be expected that the cascade of biochemical process
35 introduces an increasing degree of variability into the
measured response. In the development of spectroscopic
20
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Figure 9: Calibration (A) and test set performance (B) in prediction with PLSR of the cell viability using Raman spectra of the cell membrane of A549 cells.
The root mean squared errors of calibration (RMSEC) and prediction (RMSEP) are in the units of cell viability, which themselves are normalized to the level
in the control.

Type of spectral data
Target

95

Nucleus

RMSEC
Conc.
Viability
(µ
µM)
1.7 (0.5) 0.05 (0.01)

RMSEP
Conc.
Viability
(µ
µM)
3.4 (0.4) 0.11 (0.01)

Cytoplasm

1.5 (0.4)

0.07 (0.02)

3.7 (0.5)

0.14 (0.01)

Membrane

3.0 (0.3)

0.06 (0.02)

4.7 (0.5)

0.12 (0.01)

Combined data

6.4 (0.2)

0.15 (0.01)

8.2 (0.4)

0.19 (0.01)

% error of prediction
Conc.
Viability
6.8
(0.8)
7.5
(0.9)
9.5
(0.9)
16.3
(0.9)

11
(1)
14
(1)
12
(1)
19
(1)

Table 1: Prediction accuracies of the PLSR models based on the individual cellular components as well as the combined data, for regression against
both the cisplatin dose and the cell viability. Figures in brackets denote standard deviations.

techniques for biochemical and biomedical applications,
the analysis of model systems such as the action of cis100 platin in vitro and comparison to parallel gold standard
cytological assays is crucial. Ultimately, a more flexible
nonlinear model is desirable, whereby the spectral data
can be regressed against a user definable function. The
results demonstrate Raman spectroscopy is a powerful
105 tool to explore the molecular basis of the action of
14 | Journal Name, [year], [vol], 00–00

chemotherapeutic agents in vitro. As well as elucidating
the mechanisms of interaction, the regression models can
be employed in a predictive capacity. These findings also
suggest that the technique should be applied to the
110 spectral data from each component of the cell separately
in order to increase the accuracy in the prediction of
level of exposure and viability of the cell on the basis of
the spectral changes. It should be noted that the cell
This journal is © The Royal Society of Chemistry [year]

cultures were not synchronised according to cell cycle in
this study. Synchronisation of the cells could be
employed to further minimise the cellular variability, but
also to explore the susceptibility of the cells to the drug
42, 43
5 as a function of cell cycle.

18.
19.
60

20.
21.

‡Acknowledgements
65

22.

The authors acknowledge funding through the
Technology Sector Research (Strand III) programme of
the Irish Higher Education Authority and the Irish HEA
Programme for Research in Third Level Institutions,
Cycle 4 National Biophotonics and Imaging Platform for
15 Ireland (NBIPI).
10

23.
24.
70

25.
26.
75

References
1.
20

2.
25

3.
4.
5.

30

6.

35

7.

8.
40

9.
10.
11.

45

12.
13.
50

55

14.
15.
16.
17.

F. M. Lyng, E. O. Faolain, J. Conroy, A. D. Meade, P.
Knief, B. Duffy, M. B. Hunter, J. M. Byrne, P. Kelehan and
H. J. Byme, Experimental and Molecular Pathology, 2007,
82, 121-129.
J. Chan, S. Fore, S. Wachsman-Hogiu and T. Huser, Laser
Photon. Rev., 2008, 2, 325-349.
T. Huser, C. A. Orme, C. W. Hollars, M. H. Corzett and R.
Balhorn, J. Biophotonics, 2009, 2, 322-332.
P. Knief, C. Clarke, E. Herzog, M. Davoren, F. M. Lyng, A.
D. Meade and H. J. Byrne, 2009.
A. D. Meade, C. Clarke, F. Draux, G. D. Sockalingum, M.
Manfait, F. M. Lyng and H. J. Byrne, Anal. Bioanal. Chem.,
2010, 396, 1781-1791.
C. A. Owen, J. Selvakumaran, I. Notingher, G. Jell, L. L.
Hench and M. M. Stevens, Journal of Cellular
Biochemistry, 2006, 99, 178-186.
F. Bonnier, P. Knief, B. Lim, A. D. Meade, J. Dorney, K.
Bhattacharya, F. M. Lyng and H. J. Byrne, Analyst, 2010,
135, 3169-3177.
M. Miljkovic, T. Chernenko, M. J. Romeo, B. Bird, C.
Matthaus and M. Diem, Analyst, 2010, 135, 2002-2013.
J. Y. Ling, Q. Z. Yang, S. S. Luo, Y. Li and C. K. Zhang,
Chinese Chemical Letters, 2005, 16, 71-74.
J. Ling, S. D. Weitman, M. A. Miller, R. V. Moore and A.
C. Bovik, Applied optics, 2002, 41, 6006-6017.
I. Notingher, C. Green, C. Dyer, E. Perkins, N. Hopkins, C.
Lindsay and L. L. Hench, Journal of the Royal Society
Interface, 2004, 1, 79-90.
S. Verrier, I. Notingher, J. M. Polak and L. L. Hench, 2004.
H. Nawaz, F. Bonnier, P. Knief, O. Howe, F. M. Lyng, A.
D. Meade and H. J. Byrne, Analyst, 2010, 135, 3070-3076.
C. P. Belani, Seminars in Oncology, 2004, 31, 25-33.
D. G. Haller, Seminars in Oncology, 2004, 31, 10-16.
F. M. Muggia, Seminars in Oncology, 2004, 31, 17-24.
M. A. Szczepanski, A. Grzanka, A. Litwiniec, L.
Gackowska, I. Kubiszewska and D. Grzanka, Cell Biology
International, 2010, 34, 197-211.

This journal is © The Royal Society of Chemistry [year]

27.
28.
29.

80

30.

85

31.
32.
33.

90

34.
35.
36.

95

37.
38.
100

39.
40.
41.

105

42.

43.
110

G. Speelmans, R. Staffhorst, K. Versluis, J. Reedijk and B.
deKruijff, Biochemistry, 1997, 36, 10545-10550.
M. Akaboshi, K. Kawai, H. Maki, K. Akuta, Y. Ujeno and
T. Miyahara, Japanese Journal of Cancer Research, 1992,
83, 522-526.
R. P. Perez, European Journal of Cancer, 1998, 34, 15351542.
B. Kosmider, I. Wojcik, R. Osiecka, J. Bartkowiak, E.
Zyner, J. Ochocki and P. Liberski, Investigational New
Drugs, 2005, 23, 287-297.
T. Mosmann, Journal of Immunological Methods, 1983, 65,
55-63.
F. E. Grubbs, Technometrics, 1969, 11, 1-&.
K. Varmuza and P. Filzmoser, Introduction to Multivariate
Statistical Analysis in Chemometrics, CRC Press, Taylor
and Francis Group, Boca Raton, FL, 2009.
H. Martens and M. Martens, 2000.
A. D. Meade, C. Clarke, H. J. Byrne and F. M. Lyng,
Radiation research, 2010, 173, 225-237.
F. Westad and H. Martens, Journal of near Infrared
Spectroscopy, 2000, 8, 117-124.
J. De Gelder, K. De Gussem, P. Vandenabeele and L.
Moens, J. Raman Spectrosc., 2007, 38, 1133-1147.
P. R. T. Jess, V. Garces-Chavez, D. Smith, M. Mazilu, L.
Paterson, A. Riches, C. S. Herrington, W. Sibbett and K.
Dholakia, Optics Express, 2006, 14, 5779-5791.
A. D. Meade, F. M. Lyng, P. Knief and H. J. Byrne, Anal
Bioanal Chem, 2007, 387, 1717-1728.
I. Notingher, Sensors, 2007, 7, 1343-1358.
I. Notingher, S. Verrier, S. Haque, J. M. Polak and L. L.
Hench, Biopolymers, 2003, 72, 230-240.
F. Draux, P. Jeannesson, A. Beljebbar, A. Tfayli, N. Fourre,
M. Manfait, J. Sule-Suso and G. D. Sockalingum, Analyst,
2009, 134, 542-548.
C. G. Xie, C. Goodman, M. A. Dinno and Y. Q. Li, Optics
Express, 2004, 12, 6208-6214.
E. Ulukaya, F. Ozdikicioglu, A. Y. Oral and M. Demirci,
Toxicology in Vitro, 2008, 22, 232-239.
N. Cordes, C. Beinke, L. Plasswilm and D. van Beuningen,
Strahlentherapie Und Onkologie, 2004, 180, 157-164.
M. Jensen and W. Nerdal, European Journal of
Pharmaceutical Sciences, 2008, 34, 140-148.
J. T. Pelton and L. R. McLean, Analytical Biochemistry,
2000, 277, 167-176.
H. Martens and T. Naes, Multivariate Calibration, John
Wiley and Sons, 1994.
J. W. Black and P. Leff, Proceedings of the Royal Society of
London Series B-Biological Sciences, 1983, 220, 141-162.
A. D. Meade, PhD thesis, Dublin Institute of Technology,
2010.
H. Y. Jiao, S. L. Allinson, M. J. Walsh, R. Hewitt, K. J.
Cole, D. H. Phillips and F. L. Martin, Mutagenesis, 2007,
22, 111-116.
V. Llabjani, K. C. Jones, G. O. Thomas, L. A. Walker, R. F.
Shore and F. L. Martin, Environ. Sci. Technol., 2009, 43,
3356-3364.

Journal Name, [year], [vol], 00–00 | 15

